Cargando…

Atractylodin may induce ferroptosis of human hepatocellular carcinoma cells

BACKGROUND: It has been reported that atractylodin has a potential antitumor effect. This study aimed to investigate the effects of atractylodin on Huh7 and Hccm hepatocellular carcinoma (HCC) cells and its molecular mechanism. METHODS: Huh7 and Hccm cells were cultured in vitro, and their viability...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yongfei, Fang, Dalang, Liang, Tianyi, Pang, Hongbing, Nong, Yingdan, Tang, Libo, Yang, Ziye, Lu, Chunmiao, Han, Xiao, Zhao, Shuqi, Mo, Shutian, Meng, Yuhua, Han, Chuangye, Peng, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576678/ https://www.ncbi.nlm.nih.gov/pubmed/34790741 http://dx.doi.org/10.21037/atm-21-4386

Ejemplares similares

Laparoscopic versus open hepatectomy for hepatocellular carcinoma with cirrhosis: a single-center propensity score matching analysis
por: He, Yongfei, et al.
Publicado: (2021)

Erratum to atractylodin may induce ferroptosis of human hepatocellular carcinoma cells
Publicado: (2023)

Correlation between ABO blood group and prognosis of hepatectomy for hepatitis B virus-associated hepatocellular carcinoma
por: Liao, Yuan, et al.
Publicado: (2023)

Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model
por: He, Yongfei, et al.
Publicado: (2022)

Down regulated oncogene KIF2C inhibits growth, invasion, and metastasis of hepatocellular carcinoma through the Ras/MAPK signaling pathway and epithelial-to-mesenchymal transition
por: Mo, Shutian, et al.
Publicado: (2022)

Effect of timing of surgical resection of primary hepatocellular carcinoma on survival outcomes in elderly patients and prediction of clinical models
por: He, Yongfei, et al.
Publicado: (2021)

Biomimetic cytomembrane-coated ZIF-8-loaded DMDD nanoparticle and sonodynamic co-therapy for cancer
por: Zhao, Shuqi, et al.
Publicado: (2022)

Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis
por: Ye, Qingyan, et al.
Publicado: (2023)

Molecular mechanism of CK19 involved in the regulation of postoperative recurrence of HBV-associated primary hepatocellular carcinoma in Guangxi
por: Su, Hao, et al.
Publicado: (2021)

The Potential of Atractylodin-Loaded PLGA Nanoparticles as Chemotherapeutic for Cholangiocarcinoma
por: Muhamad, Nadda, et al.
Publicado: (2020)

Atractylodin Ameliorates Colitis via PPARα Agonism
por: Heo, Gwangbeom, et al.
Publicado: (2023)

Graft versus host disease after liver transplantation following radiotherapy for the treatment of hepatocellular carcinoma: A case report and literature review
por: Chen, Zijun, et al.
Publicado: (2022)

Natural Potent NAAA Inhibitor Atractylodin Counteracts LPS-Induced Microglial Activation
por: Yang, Longhe, et al.
Publicado: (2020)

Screening of Molecular Targets of Action of Atractylodin in Cholangiocarcinoma by Applying Proteomic and Metabolomic Approaches
por: Kotawong, Kanawut, et al.
Publicado: (2019)

Comprehensive analysis of LILR family genes expression and tumour‐infiltrating immune cells in early‐stage pancreatic ductal adenocarcinoma
por: Gao, Qiang, et al.
Publicado: (2023)

Determination and Pharmacokinetic Comparisons of Atractylodin after Oral Administration of Crude and Processed Atractylodis rhizoma
por: Xiao-Wen, Chang, et al.
Publicado: (2016)

Atractylodin Inhibits Interleukin-6 by Blocking NPM-ALK Activation and MAPKs in HMC-1
por: Chae, Hee-Sung, et al.
Publicado: (2016)

Anti-inflammatory, antioxidant and anti-virulence roles of atractylodin in attenuating Listeria monocytogenes infection
por: Xu, Lei, et al.
Publicado: (2022)

Atractylodin Induces Myosin Light Chain Phosphorylation and Promotes Gastric Emptying through Ghrelin Receptor
por: Bai, Yu, et al.
Publicado: (2017)

Determination and Tissue Distribution Comparisons of Atractylodin after Oral Administration of Crude and Processed Atractylodes Rhizome
por: Liu, Yang-Zhi, et al.
Publicado: (2017)

Atractylodin Produces Antinociceptive Effect through a Long-Lasting TRPA1 Channel Activation
por: Kanda, Hirosato, et al.
Publicado: (2021)

Prognostic value and potential molecular mechanism of the like-Sm gene family in early-stage pancreatic ductal adenocarcinoma
por: Chen, Zijun, et al.
Publicado: (2021)

Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats
por: Yu, Changchun, et al.
Publicado: (2017)

Modulatory Effects of Atractylodin and β-Eudesmol on Human Cytochrome P450 Enzymes: Potential Drug-Drug Interactions
por: Thiengsusuk, Artitaya, et al.
Publicado: (2023)

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Proteomics Analysis for Identification of Potential Cell Signaling Pathways and Protein Targets of Actions of Atractylodin and β-Eudesmol Against Cholangiocarcinoma
por: Kotawong, Kanawut, et al.
Publicado: (2020)

Atractylodin Induces Apoptosis and Inhibits the Migration of A549 Lung Cancer Cells by Regulating ROS-Mediated Signaling Pathways
por: Zhang, Tong, et al.
Publicado: (2022)

Effects of β-eudesmol and atractylodin on target genes and hormone related to cardiotoxicity, hepatotoxicity, and endocrine disruption in developing zebrafish embryos
por: Tshering, Gyem, et al.
Publicado: (2022)

Investigation of hub ferroptosis-related genes and the immune landscape in recurrent pregnancy loss and unexplained infertility using bioinformatics analysis
por: Nong, Binbin, et al.
Publicado: (2023)

PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
por: Lan, Chenlu, et al.
Publicado: (2023)

Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway
por: Vanaroj, Peeranate, et al.
Publicado: (2023)

Identification of solute carrier family genes related to the prognosis and tumor-infiltrating immune cells of pancreatic ductal adenocarcinoma
por: Meng, Yuhua, et al.
Publicado: (2022)

Atractylodin Suppresses TGF-β-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Chang, Kai-Wei, et al.
Publicado: (2021)

Atractylodin Attenuates Dextran Sulfate Sodium-Induced Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting Inflammatory Response Through the MAPK Pathway
por: Qu, Linghang, et al.
Publicado: (2021)

Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis
por: Han, Fang, et al.
Publicado: (2023)

Identification of ferroptosis related biomarkers and immune infiltration in Parkinson’s disease by integrated bioinformatic analysis
por: Xing, Na, et al.
Publicado: (2023)

Molecular Targets of Ferroptosis in Hepatocellular Carcinoma
por: Liao, Hao, et al.
Publicado: (2021)

The Critical Role of Ferroptosis in Hepatocellular Carcinoma
por: Pan, Fan, et al.
Publicado: (2022)

Correction: Chae, H.S.; et al. Atractylodin Inhibits Interleukin-6 by Blocking NPM-ALK Activation and MAPKs in HMC-1. Molecules 2016, 21, 1169
por: Chae, Hee-Sung, et al.
Publicado: (2016)

Ferroptosis: a double-edged sword mediating immune tolerance of cancer
por: Dang, Qin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_322161tnq8860ihb7pgejuonne